NDC Package 79802-200-30 Rezurock

Belumosudil Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
79802-200-30
Package Description:
1 BOTTLE in 1 CARTON / 30 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Rezurock
Non-Proprietary Name:
Belumosudil
Substance Name:
Belumosudil
Usage Information:
REZUROCK is indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.
11-Digit NDC Billing Format:
79802020030
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2564031 - belumosudil 200 MG Oral Tablet
  • RxCUI: 2564031 - belumosudil (as belumosudil mesylate) 200 MG Oral Tablet
  • RxCUI: 2564037 - REZUROCK 200 MG Oral Tablet
  • RxCUI: 2564037 - belumosudil 200 MG Oral Tablet [Rezurock]
  • RxCUI: 2564037 - Rezurock 200 MG (as belumosudil mesylate 242.5 MG) Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Kadmon Pharmaceuticals, Llc
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA214783
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    07-16-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 79802-200-30?

    The NDC Packaged Code 79802-200-30 is assigned to a package of 1 bottle in 1 carton / 30 tablet in 1 bottle of Rezurock, a human prescription drug labeled by Kadmon Pharmaceuticals, Llc. The product's dosage form is tablet and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 79802-200 included in the NDC Directory?

    Yes, Rezurock with product code 79802-200 is active and included in the NDC Directory. The product was first marketed by Kadmon Pharmaceuticals, Llc on July 16, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 79802-200-30?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 79802-200-30?

    The 11-digit format is 79802020030. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-279802-200-305-4-279802-0200-30